PCL Past Earnings Performance
Past criteria checks 0/6
PCL's earnings have been declining at an average annual rate of -60.4%, while the Medical Equipment industry saw earnings growing at 16.2% annually. Revenues have been declining at an average rate of 58.7% per year.
Key information
-60.4%
Earnings growth rate
-51.6%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | -58.7% |
| Return on equity | -38.9% |
| Net Margin | -206.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Did You Miss PCL's (KOSDAQ:241820) Impressive 208% Share Price Gain?
Mar 16
Is PCL (KOSDAQ:241820) Using Too Much Debt?
Feb 17
PCL, Inc. (KOSDAQ:241820) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Jan 27We're Not So Sure You Should Rely on PCL's (KOSDAQ:241820) Statutory Earnings
Jan 06Is PCL's (KOSDAQ:241820) Share Price Gain Of 249% Well Earned?
Dec 16Do Institutions Own PCL, Inc. (KOSDAQ:241820) Shares?
Nov 25Revenue & Expenses Breakdown
How PCL makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 8,096 | -16,698 | 10,225 | 1,642 |
| 31 Dec 23 | 8,430 | -20,318 | 10,487 | 1,724 |
| 30 Sep 23 | 3,994 | -34,911 | 11,384 | 2,296 |
| 30 Jun 23 | 7,462 | -33,898 | 11,932 | 2,884 |
| 31 Mar 23 | 19,593 | -19,208 | 11,792 | 3,038 |
| 31 Dec 22 | 37,217 | -4,018 | 10,988 | 3,502 |
| 30 Sep 22 | 46,001 | 8,937 | 12,227 | 4,544 |
| 30 Jun 22 | 55,655 | 20,711 | 11,635 | 4,468 |
| 31 Mar 22 | 52,741 | -8,445 | 10,641 | 4,930 |
| 31 Dec 21 | 46,148 | -31,669 | 9,146 | 4,826 |
| 31 Dec 20 | 53,683 | 19,509 | 4,193 | 4,211 |
Quality Earnings: A241820 is currently unprofitable.
Growing Profit Margin: A241820 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A241820 is unprofitable, and losses have increased over the past 5 years at a rate of 60.4% per year.
Accelerating Growth: Unable to compare A241820's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A241820 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (4.1%).
Return on Equity
High ROE: A241820 has a negative Return on Equity (-38.94%), as it is currently unprofitable.